Multiple Factor Analysis of Depression and/or Anxiety in Patients with Acute Exacerbation Chronic Obstructive Pulmonary Disease

References

• American Lung Association Epidemiology and Statistics Unit. Trends in COPD (Chronic Bronchitis and Emphysema): morbidity and mortality; 2013 Available from: https://www.lung.org/assets/documents/research/copd-trend-report.pdf. Accessed 1014, 2018.
   Google Scholar
• MykletunA, BjerkesetO, ØverlandS, PrinceM, DeweyM, StewartR. Levels of anxiety and depression as predictors of mortality: the HUNT study. Br J Psychiatry. 2009;195(2):118–125. doi:10.1192/bjp.bp.108.05486619648541
   PubMed Web of Science ®Google Scholar
• de VoogdJN, WempeJB, PostemaK, et al. More evidence that depressive symptoms predict mortality in COPD patients: is type D personality an alternative explanation? Ann Behavior Med. 2009;38(2):86–93. doi:10.1007/s12160-009-9105-8
   PubMed Web of Science ®Google Scholar
• HynninenKM, BreitveMH, WiborgAB, et al. Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res. 2005;59:429–443. doi:10.1016/j.jpsychores.2005.04.00716310027
   PubMed Web of Science ®Google Scholar
• YohannesAM, BaldwinRC, ConnollyMJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry. 2000;15:1090–1096. doi:10.1002/1099-1166(200012)15:12<1090::AID-GPS249>3.0.CO;2-L11180464
   PubMed Web of Science ®Google Scholar
• Shyam Chand Chaudhary SNAT. Prevalence of psychiatric comorbidities in chronic obstructive pulmonary disease patients. Lung India. 2016;2(32):174–178.
   Google Scholar
• Putman-CasdorphH, McCroneS. Chronic obstructive pulmonary disease, anxiety, and depression: state of the science. Heart Lung. 2009;38(1):34–47. doi:10.1016/j.hrtlng.2008.02.00519150529
   PubMed Web of Science ®Google Scholar
• XuW, ColletJP, ShapiroS, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med. 2008;178(9):913–920. doi:10.1164/rccm.200804-619OC18755925
   PubMed Web of Science ®Google Scholar
• GiardinoND, CurtisJL, AndreiA-C, et al. Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study. Respir Res. 2010;11(1):29. doi:10.1186/1465-9921-11-2920214820
   PubMed Web of Science ®Google Scholar
• NgT-P, NitiM, TanW-C, CaoZ, OngK-C, EngP. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167(1):60–67. doi:10.1001/archinte.167.1.6017210879
   PubMed Web of Science ®Google Scholar
• GudmundssonG, GislasonT, JansonC, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J. 2005;26(3):414–419. doi:10.1183/09031936.05.0007850416135721
   PubMed Web of Science ®Google Scholar
• Al-ShairK, KolsumU, DockryR, et al. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res. 2011;12(1):3. doi:10.1186/1465-9921-12-321208443
   PubMed Web of Science ®Google Scholar
• SemizM, YildirimO, CananF, et al. Elevated neutrophil/lymphocyte ratio in patients with schizophrenia. Psychiatr Danub. 2014;26(3):220–225.25191768
   PubMed Web of Science ®Google Scholar
• ÖzdinS, BökebÖ. Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in different stages of schizophrenia. Psychiatry Res. 2018.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung disease. Strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2019;31(EB/OL). Available from: https://goldcopd.org/gold-report/. Accessed December 2, 2018.
   Google Scholar
• HurstJR, WedzichaJA. What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines. Thorax. 2007;62(3):198–199. doi:10.1136/thx.2007.07788317329557
   PubMed Web of Science ®Google Scholar
• WedzichaJA, SeemungalTA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. doi:10.1016/S0140-6736(07)61382-817765528
   PubMed Web of Science ®Google Scholar
• SeemungalTA, DonaldsonGC, PaulEA, BestallJC, JeffriesDJ, WedzichaJA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418–1422. doi:10.1164/ajrccm.157.5.97090329603117
   PubMed Web of Science ®Google Scholar
• BurgeS, WedzichaJA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl. 2003;41:46s–53s. doi:10.1183/09031936.03.0007800212795331
   PubMedGoogle Scholar
• JancaA, UstünTB, EarlyTS, et al. The ICD-10 symptom checklist: a companion to the ICD-10 classification of mental and behavioural disorders. Soc Psychiatry Psychiatr Epidemiol. 1993;28(5):239–242. doi:10.1007/BF07887438284737
   PubMed Web of Science ®Google Scholar
• WenbinC, XianglinP. Diagnostics. People’s Health Press; 2007:538.
   Google Scholar
• NianfengG. Psychological Consultant. national press; 2005:179.
   Google Scholar
• BordoniB, MarelliF, MorabitoB, et al. Depression,anxiety and chronic pain in patients with chronic obstructive pulmonary disease: the influence of breath. Monaldi Arch Chest Dis. 2017;87(1):811．. doi:10.4081/monaldi.2017.811
   PubMed Web of Science ®Google Scholar
• JonesP, HardingG, WiklundI, et al. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J. 2009;18:208–215. doi:10.4104/pcrj.2009.0005319690787
   PubMedGoogle Scholar
• JonesPW, HardingG, BerryP, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34:648–654. doi:10.1183/09031936.0010250919720809
   PubMed Web of Science ®Google Scholar
• CAT Development Steering Group. COPD assessment test-healthcare professional user guide[J].[2014-05]. Available from: http://www.catestonline.org/images/UserGuides/CATHCPUser%20guideEn.pdf, 2018. Accessed 131, 2011.
   Google Scholar
• DowsonC, LaingR, BarracloughR, et al. The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study. N Z Med J. 2001;114:447–449.11700772
   PubMed Web of Science ®Google Scholar
• Di MarcoF, VergaM, ReggenteM, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100:1767–1774. doi:10.1016/j.rmed.2006.01.02616531031
   PubMed Web of Science ®Google Scholar
• HananiaNA, MullerovaH, LocantoreNW, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011;183(5):604–611. doi:10.1164/rccm.201003-0472OC20889909
   PubMed Web of Science ®Google Scholar
• XueliS. Psychiatry. Higher Education Press; 2013:325–326.
   Google Scholar
• PumarMI, GrayCR, WalshJR, et al. Anxiety and depression-Important psychological comorbidities of COPD. J Thorac Dis. 2014;6(11):1615.25478202
   PubMed Web of Science ®Google Scholar
• KunikME, RoundyK, VeazeyC, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127:1205–1211. doi:10.1378/chest.127.4.1205.15821196
   PubMed Web of Science ®Google Scholar
• BosleyCM, CordenZM, ReesPJ, et al. Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J. 1996;9:2346–2350. doi:10.1183/09031936.96.09112346.8947083
   PubMed Web of Science ®Google Scholar
• GudmundssonG, GislasonT, JansonC, et al. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med. 2006;100(1):87–93. doi:10.1016/j.rmed.2005.04.00315893921
   PubMed Web of Science ®Google Scholar
• MikkelsenRL, MiddelboeT, PisingerC, StageKB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry. 2004;58:66–70. doi:10.1080/08039480310000824
   Web of Science ®Google Scholar
• AlmagroP, BarreiroB, Ochoa de EchaguenA, et al. Risk factors for hospital admissions in patients with chronic obstructive pulmonary disease. Respiration. 2006;73(3):311–317. doi:10.1159/00008809216155352
   PubMed Web of Science ®Google Scholar
• RegvatJ, ŽmitekA, VegnutiM, KošnikM, ŠuškovičS. Anxiety and depression during hospital treatment of exacerbation of chronic obstructive pulmonary disease. J Int Med Res. 2011;39(3):1028–1038. doi:10.1177/14732300110390033821819737
   PubMed Web of Science ®Google Scholar
• KimHF, KunikME, MolinariVA, et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics. 2010;41(6):465–471. doi:10.1176/appi.psy.41.6.465
   Web of Science ®Google Scholar
• WiesbeckGA, KuhlHC, YaldizliO, et al. Tobacco smoking and depression–results from the WHO/ISBRA study. Neuropsychobiology. 2008;57:26–31. doi:10.1159/00012311918424908
   PubMed Web of Science ®Google Scholar
• MineurYS, PicciottoMR. Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis. Trends Pharmacol Sci. 2010;31(12):580–586. doi:10.1016/j.tips.2010.09.00420965579
   PubMed Web of Science ®Google Scholar
• SindenNJ, StockleyRA. Systemic inflammation and comorbidity in COPD: a result of ‘overspill’ of inflammatory mediators from the lungs? Review of the evidence. Thorax. 2010;65(10):930–936. doi:10.1136/thx.2009.13026020627907
   PubMed Web of Science ®Google Scholar
• HynninenMJ, PallesenS, NordhusIH. Factors affecting health status in COPD patients with co-morbid anxiety or depression. Int J Chron Obstruct Pulmon Dis. 2007;2(3)::323–328.
   PubMedGoogle Scholar
• SchneiderB, PrvulovicD, Oertel -knochelV, et al. Biomarkers for major depression and its delineation from neurodegenerative disorders. Prog Neurobiol. 2011;95(4):703–717. doi:10.1016/j.pneurobio.2011.08.00121854829
   PubMed Web of Science ®Google Scholar
• MantovaniA, CassatellaMA, CostantiniC, et al. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011;11(8):519–53121785456
   PubMed Web of Science ®Google Scholar
• ZahorecR. Ratio of neutrophil to lymphocyte counts-Rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5–14.11723675
   PubMedGoogle Scholar
• JagerCPD, WijkPTV, MathoeraRB. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care. 2010;14(5):R192. doi:10.1186/cc930921034463
   PubMed Web of Science ®Google Scholar
• PaliogiannisP, FoisAG, SotgiaS, et al. Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives. Eur Respir Rev. 2018;7(147):170113. doi:10.1183/16000617.0113-2017
   Web of Science ®Google Scholar
• WilliamsKA, Labidi-GalySI, TerryKL, et al. Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer. Gynecol Oncol. 2014;132:542–550. doi:10.1016/j.ygyno.2014.01.02624462730
   PubMed Web of Science ®Google Scholar
• RoxburghCS, McMillanDC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6(1):149–163. doi:10.2217/fon.09.13620021215
   PubMed Web of Science ®Google Scholar
• KacanT, BabacanNA, SekerM, et al. Could the neutrophil to lymphocyte ratio be a poor prognostic factor for non small cell lung cancers? Asian Pac J Cancer Prev. 2014;15(5):2089–2094. doi:10.7314/APJCP.2014.15.5.208924716939
   PubMedGoogle Scholar
• PaliogiannisP, ScognamilloF, BellomoM, et al. Neutrophil to lymphocyte ratio as a predictor of thyroid papillary carcinoma. Act Med Mediterr. 2015;31:371–375.
   Web of Science ®Google Scholar
• AzabB, BhattVR, PhookanJ, et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol. 2012;19(1):217–224. doi:10.1245/s10434-011-1814-021638095
   PubMed Web of Science ®Google Scholar
• StotzM, GergerA, EisnerF, et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer. 2013;109(2):416–421. doi:10.1038/bjc.2013.33223799847
   PubMed Web of Science ®Google Scholar
• DuffyBK, GurmHS, RajagopalV, et al. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol. 2006;97:993–996. doi:10.1016/j.amjcard.2005.10.03416563903
   PubMed Web of Science ®Google Scholar
• ArbelY, FinkelsteinA, HalkinA, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis. 2012;225(2):456–460. doi:10.1016/j.atherosclerosis.2012.09.00923040448
   PubMed Web of Science ®Google Scholar
• BoschF, RibesJ, BorràsJ. Epidemiology of Primary Liver Cancer. Semin Liver Dis. 1999;19(03):271–285. doi:10.1055/s-2007-100711710518307
   PubMed Web of Science ®Google Scholar
• PierceCN, LarsonDF. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion. 2005;20(2):83–90. doi:10.1191/0267659105pf793oa15918445
   PubMed Web of Science ®Google Scholar
• HampoleCV, MehrotraAK, ThenappanT, Gomberg-MaitlandM, ShahSJ. Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol. 2009;104(6):868–872. doi:10.1016/j.amjcard.2009.05.01619733726
   PubMed Web of Science ®Google Scholar
• Lippi G, Targher G, Montagnana M, et al. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients[J]. Archives of pathology&laboratory medicine, 2009,133(4):628–632.
   Google Scholar
• TonelliM, SacksF, ArnoldM, MoyeL, DavisB, PfefferM; for the Cholesterol and Recurrent Events (CARE) Trial Investigators. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008;117(2):163–168. doi:10.1161/CIRCULATIONAHA.107.72754518172029
   PubMed Web of Science ®Google Scholar